Skip to content
ClinCalc Pro
Menu
paediatrics

Withdrawal Assessment Tool (WAT-1) for Paediatric Iatrogenic Withdrawal

Validated 11-item tool for assessing iatrogenic opioid and benzodiazepine withdrawal in critically ill children. Assesses symptoms over the past 12 hours plus a 2-minute observation period.

Score interpretation

No Significant Withdrawal 0–2

WAT-1 < 3 -- no significant iatrogenic withdrawal detected

→ Continue the current weaning plan per the unit protocol. Score WAT-1 at least twice daily (every 12 h) from the first wean until 72 h after the last dose. Non-pharmacological comfort: swaddling, positioning, skin-to-skin, minimal stimulation, cluster care.

Significant Withdrawal -- Manage Opioid/Benzo Wean 3–12

WAT-1 >= 3 -- significant iatrogenic withdrawal; treatment modification required

→ Pause or slow the opioid / benzodiazepine wean; give a rescue dose and consider increasing the daily dose before restarting a slower wean, per the unit weaning protocol. Consider adjuncts (e.g. clonidine) or conversion to enteral methadone after prolonged infusions — take doses from a children's formulary and with the PICU pharmacist. Minimise stimulation (low light, noise reduction, cluster care); support the family; document scores.

Interpretation bands for the WAT-1. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.